west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "抗癫痫药物" 40 results
  • 儿童失神癫痫药物治疗预后的研究进展

    儿童失神癫痫(Childhood absence epilepsy,CAE)是由多种遗传病因引起的最常见的特发性全面性非惊厥性癫痫,与 CAE 预后相关的因素众多,但目前尚未有确切共识的指南供临床参考,本文对 CAE 患儿药物治疗、预后情况和预后影响因素作一综述,以期能为 CAE 患儿临床的诊疗实践提供一定的参考和意见。

    Release date:2021-12-30 06:08 Export PDF Favorites Scan
  • 脑血管疾病继发癫痫:实验回顾和临床危险因素的荟萃分析

    癫痫发作可能发生在刚刚卒中发生以后或在很久以后。此外,癫痫也常发生在患有脑白质疏松的患者。尽管卒中后早期痫性发作被广泛研究,卒中后癫痫(Post-stroke epilepsy,PSE)和与脑白质疏松相关癫痫(Epilepsy associated with leukoaraiosis,EAL)研究较少。文章目的是回顾PSE和EAL相关病理生理学,预后和治疗情况。并进行了广泛的文献检索,以筛选关于PSE和EAL的动物实验和临床文章。同时,还对纳入研究中PSE和EAL发生的风险因素进行了系统的回顾分析。PSE是由于瘢痕组织内和其附近神经元兴奋性增加引起的。白质改变在EAL中的作用尚待阐明。荟萃分析显示皮质受累[ OR=3.71,95% CI (2.34, 5.90),P < 0.001],脑出血[ OR=2.41,95% CI (1.57, 3.70),P < 0.001]和早期痫性发作[ OR=4.43,95% CI (2.36, 8.32),P < 0.001]显著增加PSE发生风险。关于EAL,没有前瞻性、基于人群的研究评估不同变量对癫痫发作风险的影响。关于PSE治疗的研究相对有限。PSE药物控制效果通常良好。有关危险因素、预后和EAL治疗的资料较缺乏。PSE的病理生理学和危险因素是明确的,但在EAL中仍需进一步阐明。PSE和EAL的治疗依赖于临床医生的判断,并应在个人基础上进行调控。

    Release date:2017-05-24 05:46 Export PDF Favorites Scan
  • 抗癫痫药物对肾功能损伤的研究进展

    癫痫是神经科常见的慢性致残性疾病,目前主要依赖药物治疗。抗癫痫药物(AEDs)对肝功能、内分泌系统等的常见不良反应已受到普遍重视,但其对肾功能的影响却容易被忽视。本文总结了目前常用的 AEDs 的药物动力学特点及其与肾功能的联系,包括经典的一代药物(丙戊酸、卡马西平)、二代药物(左乙拉西坦、拉莫三嗪、托吡酯、奥卡西平)以及三代新型药物(拉考沙胺、吡仑帕奈)。AEDs 引起的肾功能损伤的可分为剂量依赖性和免疫相关非剂量依赖性,前者与肾脏细胞直接毒性损伤或内分泌代谢异常有关,包括 Fanconi 综合征、低钠血症、低钾血症、代谢性酸中毒等,一代 AEDs、托吡酯等;后者主要指 AEDs 高敏感综合征,常见于卡马西平和拉莫三嗪。用药方案个体化及早期监测是避免肾功能损伤的关键,生物利用度完全且稳定、长半衰期较短、线性药代动力学特征、蛋白结合率低、肝酶诱导作用少、低代谢产物活性 AEDs 安全性更高、有效性更佳。

    Release date:2021-02-27 02:57 Export PDF Favorites Scan
  • 癫痫及抗癫痫药物对育龄期女性患者生殖内分泌的影响

    癫痫是神经系统最常见的慢性疾病之一。癫痫患者结婚率、生育率低。多囊卵巢、多囊卵巢综合症、高雄激素血症、性功能障碍等常见于女性癫痫患者(Women with epilepsy,WWE)。癫痫放电或抗癫痫药物(AEDs)影响下丘脑-垂体-卵巢轴系统调节,引起体内激素水平改变,因而 WWE 易患生殖内分泌疾病。文章就癫痫及 AEDs 对育龄期 WWE 生殖内分泌的影响进行综述。

    Release date:2018-01-20 10:51 Export PDF Favorites Scan
  • 癫痫患儿注意缺陷多动障碍筛查、诊断和管理的系统评价:国际抗癫痫联盟儿科委员会共病工作组共识

    注意缺陷多动障碍(Attention-deficit/hyperactivity disorder,ADHD)是癫痫患儿一种常见且富有挑战的共患病。国际抗癫痫联盟(ILAE)儿科委员会共病工作组发现,关键问题在于识别和管理癫痫患儿中的 ADHD。对支持这些问题的方法的证据进行了系统评价,并根据美国神经病学学会实践参数的标准进行了整理和分级。遵循系统评价和 Meta 分析优先报告的条目(Preferred Reporting Items for Systematic Reviews and Meta-Analyses,PRISMA)要求,使用 PROSPERO 注册 (CRD42018094617)。与女性癫痫患儿相比,男性患儿无更高的共患 ADHD 风险(Level A)。孕期使用丙戊酸钠与子代注意力不集中和多动相关(1 项 I 级研究),且有智力和发育障碍的患儿合并 ADHD 的风险更高(A 级)。起病年龄对是否合并 ADHD 的影响尚不明确(U 级),但是发作控制欠佳的患儿合并 ADHD 的风险更高(B 级)。ADHD 的筛查应该从 6 岁或者明确诊断时开始,并且每年筛查一次(U 级),在抗癫痫药物调整后也应该重新评估(U 级)。ADHD 的诊断应该由受过 ADHD 专业培训的医务工作者参与(U 级)。支持使用优势和困难问卷筛查工具(B 级)。强烈建议有学习障碍的癫痫患儿进行正式的认知测试(U 级)。多药治疗的患儿出现行为问题的比例较单药治疗者更高(C 级)。丙戊酸钠可以加剧失神发作患儿的注意力集中障碍(A 级)。哌甲酯在癫痫患儿中耐受性及疗效均良好(B 级)。支持阿托莫西汀耐受性好的证据尚有限(C 级)。多学科参与过渡期和成人 ADHD 的诊治至关重要(U 级)。总之,虽然可以对一些研究问题提出建议,但这项系统评价强调了开展更全面、更有针对性的大样本前瞻性研究的必要性。

    Release date:2019-11-14 10:46 Export PDF Favorites Scan
  • The effects of oxcarbazepine, levetiracetam, and lamotrigine on thyroid hormones in male adults with epilepsy

    Objectives To investigate the effects of new antiepileptic drugs [oxcarbazepine (OXC), levetiracetam (LEV), lamotrigine (LTG)] on thyroid hormones in male adults with epilepsy. Methods Thirty-eight newly diagnosed male adult patients with epilepsy were enrolled in the Epilepsy Center of Sichuan Province People's Hospital from April 2015 to November 2016. The diagnosis was in line with the classification of epilepsy defined by the International League Against Epilepsy (ILAE, 1981). Only patients with generalized or secondary generalized epilepsy were recruited into the present study. Individual treatment with OXC, LEV, or LTG was randomly assigned to the 38 patients. Thyroid hormones was measured before treatment and 6 months after taking the medicine. Followed by an analysis of the comparison between the treated patients and healthy volunteers (healthy controls) as well as the changes and differences between the patients themselves before and after treatment. Results There was no significant difference in the thyroid hormone levels between male patients with epilepsy before taking the medicine and healthy controls (P>0.05). After 6 months, total thyroxine (TT4) and free thyroxine (FT4) in OXC group was significantly lower than the baseline (P<0.05). However, the thyroid hormone levels in the LEV group and LTG group showed no statistical difference before and after treatment (P>0.05). Conclusions OXC can reduce serum total thyroxine (TT4) and free thyroxine (FT4), which might be harmful to thyroid hormone of patients.

    Release date:2018-09-18 10:17 Export PDF Favorites Scan
  • 拉考沙胺—部分性癫痫发作的新选择

    癫痫是神经科最常见的疾病之一,目前其治疗主要依赖于药物。传统抗癫痫药物(AEDs)通常不良反应较多,多和其他药物之间存在相互作用。拉考沙胺(LCM)作为第三代新型 AEDs,于 2008 年在美国上市,是目前唯一已知选择性作用于慢失活钠通道 AEDs,现欧美已获得≥4 岁部分性癫痫患者添加及单药治疗的适应证。在中日临床试验中作为≥16 岁难治性部分性发作癫痫患者的添加治疗,16 周 50% 有效率高达 49.2%。此外,真实世界研究也证明了 LCM 早期添加治疗 6 个月癫痫无发作率可达 45.5%。安全性方面,长达 8 年的开放标签研究显示长期用药耐受性好,不良反应多为轻中度,主要包括头晕、头痛、恶心、复视等。

    Release date:2019-11-14 10:46 Export PDF Favorites Scan
  • Timing of long term antiepileptic drug therapy for stroke related seizures

    ObjectiveThis study aimed to explore the timing of the long-term antiepileptic drugs (AEDs) therapy in patients with stroke related seizures. MethodsWe enrolled 90 Patients with post-stroke seizures who diagnosed in neurology and epilepsy specialist clinic of Tianjin Medical University General Hospital and followed up for at least 12 months from September 2014 to August 2016. The patients were divided into early-onset seizure group (occurring within 2 weeks of stroke) and late-onset seizure group (occurring after 2 weeks of stroke).The two groups were subdivided into treated and untreated group after the first seizure. ResultsThe patients were followed up for 12~96m (median 20m). 31 patients in ES group, 19 of which in treated group and 12 of which in untreated group. 59 patients in LS group, 36 of which in treated group and 23 of cases in untreated group. The recurrence rate of second seizures occurred in each group and the comparison between the subgroups in the 3rd, 6th, 9th and 12th mouth of follow-up as follows. 1 LS group compared with the group of ES, the recurrence rate of second seizures was high (25.81%~38.71% vs. 49.15%~69.49%), and there was statistical difference (P < 0.05). 2 The recurrence rate of ES in untreated group was lower than that in untreated LS group (16.77% 33.33% vs. 56.52% 73.91%), but only in 3m and 12m the difference was statistically significant (P < 0.05). 3 There was on statistically significant different in ES treated group compared to untreated group, LS treated group compared to untreated group, ES treated group compared to LS treated group (P > 0.05). Both in group of ES and LS, The ratio of seizure recurred patients at different time points during follow-up period was highest at the time of 3m, 3 6m followed, within six months respectively as high as 91.67% and 76.59%. ConclusionOnly one early-onset seizure after stroke can be suspended long-term AEDs treatment, once it recurred that indicates the need for treatment. However, the recurrence rate of late-onset seizure was higher than that of early-onset seizure and it should be given long term AEDs treatment after the first seizure.

    Release date:2017-01-22 09:09 Export PDF Favorites Scan
  • A Meta-analysis of effectiveness and safety of steroids combined with antiepileptic drugs in the treatment of children with epileptic electrical status during sleep

    ObjectiveTo systematically evaluate the efficacy of steroids combined with antiepileptic drugs compared with alone antiepileptic drugs in the treatment of children with epileptic electrical status during sleep to provide evidence-based medical basis for its treatment.MethodsElectronic searches were maded in PubMed, Embase database, Cochrane Library, CNKI, Wanfang and the Chinese biomedical literature database for the literature about steroids combined with antiepileptic drugs compared with alone antiepileptic drugs in the treatment, and retrieval time is from January 1990 to October 2020. Two evaluators independently screened literature, extracted data, evaluated literature quality and risk of bias and checked each other. Meta analysis was performed by stata16.0 software.ResultsA total of 679 children with ESES were included in 10 studies, including 9 randomized controlled trials and 1 retrospective cohort study. Meta analysis results showed that there were statistically significant differences in clinical improvement rate [RR=1.31, 95%CI (1.21, 1.42), P<0.01], electroencephalogram discharge improvement rate [RR=1.35, 95%CI (1.25, 1.46), P<0.01] and cognitive intelligence score [SMD=1.19, 95%CI (0.80, 1.57), P<0.01] between steroids combined with antiepileptic drugs group and alone antiepileptic drugs group after 6 months follow-up. The incidence of adverse reactions in steroids combined with antiepileptic drugs group was higher than that in alone antiepileptic drugs group, and the difference was statistically significant [RR=4.13, 95%CI (1.06, 16.13), P<0.01]. All adverse reactions improved or disappeared after drug withdrawal.ConclusionCompared with alone antiepileptic drugs, steroids combined with antiepileptic drugs group has advantages in controlling epileptic seizures, improving electroencephalogram abnormalities and improving cognitive ability, and it is relatively safe.

    Release date:2021-06-24 01:24 Export PDF Favorites Scan
  • 基于文献回顾及临床经验的欧洲专家意见:丙戊酸在女童和育龄期女性癫痫患者中的使用意见

    丙戊酸(Valproate,VPA)是一种广谱抗癫痫药物(Antiepileptic drugs,AEDs),相较于其他 AEDs,其对儿童癫痫综合征和特发性全面性癫痫(Idiopathic generalized epilepsy,IGE)更为有效。2018 年,欧洲药品管理局(European Medicines Agency,EMA)就 VPA 在女童和育龄期女性中的使用颁布了全新的限制条例,以避免患者在妊娠期间暴露于 VPA。此次对现有限制条例的进一步加强在患者和医学界中引发了广泛的争议和讨论。在育龄期女性中,仍有很大比例的癫痫综合征患者在使用 VPA,此外,VPA 替代药物的致畸信息缺乏,均为如何管理此类患者带来了不确定性。在本意见声明中,欧洲癫痫专家组基于文献回顾和临床经验,提出了针对不同癫痫类型的女童、育龄期女性和孕妇 AEDs 治疗的综合建议。

    Release date:2021-04-25 09:50 Export PDF Favorites Scan
4 pages Previous 1 2 3 4 Next

Format

Content